Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 19.54 Million CAD | 47.39% |
| 2022 | 13.25 Million CAD | 223.55% |
| 2021 | 4.09 Million CAD | 108.28% |
| 2020 | 1.96 Million CAD | 1340.36% |
| 2019 | 136.59 Thousand CAD | -75.05% |
| 2018 | 547.54 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 19.02 Million CAD | -1.16% |
| 2024 Q1 | 19.24 Million CAD | -1.49% |
| 2023 Q1 | 14.52 Million CAD | 9.56% |
| 2023 FY | 19.54 Million CAD | 47.39% |
| 2023 Q2 | 14.94 Million USD | 2.86% |
| 2023 Q3 | 14.44 Million USD | -3.34% |
| 2023 Q4 | 19.54 Million CAD | 35.29% |
| 2022 FY | 13.25 Million CAD | 223.55% |
| 2022 Q4 | 13.25 Million CAD | 29.15% |
| 2022 Q3 | 10.26 Million CAD | -3.18% |
| 2022 Q2 | 10.6 Million CAD | 17.86% |
| 2022 Q1 | 8.99 Million CAD | 119.56% |
| 2021 Q1 | 1.54 Million CAD | 554.28% |
| 2021 FY | 4.09 Million CAD | 108.28% |
| 2021 Q4 | 4.09 Million CAD | 43.67% |
| 2021 Q3 | 2.85 Million CAD | 12.67% |
| 2021 Q2 | 2.53 Million CAD | 64.35% |
| 2020 FY | 1.96 Million CAD | 1340.36% |
| 2020 Q3 | 855.33 Thousand CAD | 18.83% |
| 2020 Q2 | 719.77 Thousand CAD | 0.0% |
| 2020 Q1 | - CAD | -100.0% |
| 2020 Q4 | 235.42 Thousand CAD | -72.48% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | 705.44 Thousand CAD | 0.0% |
| 2019 FY | 136.59 Thousand CAD | -75.05% |
| 2018 FY | 547.54 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -1439.886% |
| Arrayit Corporation | 1 Million USD | -1853.355% |
| Atlantic International Corp. | 4.43 Million USD | -340.477% |
| Biocept, Inc. | 30.87 Million USD | 36.705% |
| Bioqual, Inc. | 56.58 Million USD | 65.468% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -8325.378% |
| DermTech, Inc. | 121.93 Million USD | 83.973% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.533% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -9.92% |
| iMD Companies, Inc. | 190.13 Thousand USD | -10177.404% |
| IDenta Corp. | 1.52 Million USD | -1177.805% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -50.074% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -136.807% |
| InVitro International | 1.53 Million USD | -1173.863% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 27.189% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -845105.363% |
| Medical Imaging Corp. | 4.19 Million USD | -366.195% |
| NovelStem International Corp. | 2.25 Million USD | -766.744% |
| Optigenex Inc. | 1.88 Million USD | -934.859% |
| PharmChem, Inc. | 2.76 Million USD | -606.589% |
| Proteome Sciences plc | 14.58 Million USD | -33.972% |
| Response Genetics, Inc | 48.88 Million USD | 60.025% |
| Rennova Health, Inc. | 20.57 Million USD | 5.014% |
| RushNet, Inc. | 6.04 Million USD | -223.122% |
| ScreenPro Security Inc. | 1.26 Million USD | -1449.214% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -4036.367% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -2688.995% |
| Todos Medical Ltd. | 15.26 Million USD | -27.996% |